Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

The effects of genetic polymorphisms of IL-6, IL-8, and IL-10 on Helicobacter pylori-induced gastroduodenal diseases in Korea.

Kang JM, Kim N, Lee DH, Park JH, Lee MK, Kim JS, Jung HC, Song IS.

J Clin Gastroenterol. 2009 May-Jun;43(5):420-8. doi: 10.1097/MCG.0b013e318178d1d3.

PMID:
19077731
2.

The effects of genetic polymorphisms of IL-1 and TNF-A on Helicobacter pylori-induced gastroduodenal diseases in Korea.

Kim N, Cho SI, Yim JY, Kim JM, Lee DH, Park JH, Kim JS, Jung HC, Song IS.

Helicobacter. 2006 Apr;11(2):105-12. Erratum in: Helicobacter. 2006 Jun;11(3):215.

PMID:
16579840
3.

Polymorphisms of interleukin-1 and interleukin-2 genes in patients with gastric cancer in Korea.

Shin WG, Jang JS, Kim HS, Kim SJ, Kim KH, Jang MK, Lee JH, Kim HJ, Kim HY.

J Gastroenterol Hepatol. 2008 Oct;23(10):1567-73. doi: 10.1111/j.1440-1746.2008.05479.x. Epub 2008 Aug 28.

PMID:
18761558
4.

The interleukin-8-251 A allele is associated with increased risk of noncardia gastric adenocarcinoma in Helicobacter pylori-infected Koreans.

Ye BD, Kim SG, Park JH, Kim JS, Jung HC, Song IS.

J Clin Gastroenterol. 2009 Mar;43(3):233-9. doi: 10.1097/MCG.0b013e3181646701.

PMID:
18542040
5.

The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population.

Ohyauchi M, Imatani A, Yonechi M, Asano N, Miura A, Iijima K, Koike T, Sekine H, Ohara S, Shimosegawa T.

Gut. 2005 Mar;54(3):330-5.

6.

Polymorphisms of the IL-6, IL-8 and IL-10 genes and the risk of gastric pathology in patients infected with Helicobacter pylori.

Ramis IB, Vianna JS, Gonçalves CV, von Groll A, Dellagostin OA, da Silva PEA.

J Microbiol Immunol Infect. 2017 Apr;50(2):153-159. doi: 10.1016/j.jmii.2015.03.002. Epub 2015 Mar 24.

7.

The discrepancy between genetic polymorphism of p53 codon 72 and the expression of p53 protein in Helicobacter pylori-associated gastric cancer in Korea.

Kim N, Cho SI, Lee HS, Park JH, Kim JH, Kim JS, Jung HC, Song IS.

Dig Dis Sci. 2010 Jan;55(1):101-10. doi: 10.1007/s10620-008-0688-x. Epub 2009 Jan 29.

PMID:
19184427
8.

Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome.

Zambon CF, Basso D, Navaglia F, Belluco C, Falda A, Fogar P, Greco E, Gallo N, Rugge M, Di Mario F, Plebani M.

Cytokine. 2005 Feb 21;29(4):141-52. Epub 2004 Dec 8.

PMID:
15652446
9.

Combination of Helicobacter pylori infection and the interleukin 8 -251 T > A polymorphism, but not the mannose-binding lectin 2 codon 54 G > A polymorphism, might be a risk factor of gastric cancer.

Chang YW, Oh CH, Kim JW, Lee JW, Park MJ, Shim JJ, Lee CK, Jang JY, Dong SH, Kim HJ, Kim SS, Kim BH.

BMC Cancer. 2017 May 30;17(1):388. doi: 10.1186/s12885-017-3378-2.

10.

Polymorphisms of matrix metalloproteinase-7 and chymase are associated with susceptibility to and progression of gastric cancer in Japan.

Sugimoto M, Furuta T, Kodaira C, Nishino M, Yamade M, Ikuma M, Sugimura H, Hishida A.

J Gastroenterol. 2008;43(10):751-61. doi: 10.1007/s00535-008-2221-6. Epub 2008 Oct 29.

PMID:
18958543
11.

HELICOBACTER PYLORI INFECTION AND IMMUNE PROFILE OF PATIENTS WITH DIFFERENT GASTRODUODENAL DISEASES.

Vinagre RMDF, Vinagre IDF, Vilar-E-Silva A, Fecury AA, Martins LC.

Arq Gastroenterol. 2018 Apr-Jun;55(2):122-127. doi: 10.1590/S0004-2803.201800000-21.

12.

Association of polymorphisms in virulence factor of Helicobacter pylori and gastroduodenal diseases in South Korea.

Kim JY, Kim N, Nam RH, Suh JH, Chang H, Lee JW, Kim YS, Kim JM, Choi JW, Park JG, Lee YS, Lee DH, Jung HC.

J Gastroenterol Hepatol. 2014 May;29(5):984-91. doi: 10.1111/jgh.12509.

PMID:
24372834
13.

Association between interleukin-8 gene -251 T/A polymorphism and the risk of peptic ulcer disease: a meta-analysis.

Yin YW, Hu AM, Sun QQ, Zhang BB, Wang Q, Liu HL, Zeng YH, Xu RJ, Zhang SJ, Shi LB.

Hum Immunol. 2013 Jan;74(1):125-30. doi: 10.1016/j.humimm.2012.09.006. Epub 2012 Sep 20.

PMID:
23000201
14.

Novel interleukin-4 and interleukin-1 receptor antagonist gene variations associated with non-cardia gastric cancer in Japan: comprehensive analysis of 207 polymorphisms of 11 cytokine genes.

Seno H, Satoh K, Tsuji S, Shiratsuchi T, Harada Y, Hamajima N, Sugano K, Kawano S, Chiba T.

J Gastroenterol Hepatol. 2007 May;22(5):729-37.

PMID:
17444864
15.

IL-6-6331 (T/C, rs10499563) is associated with decreased risk of gastric cancer in Northern Chinese.

Yang L, Sun MJ, Liu JW, Xu Q, Yuan Y.

Asian Pac J Cancer Prev. 2013;14(12):7467-72.

16.

TNF and LTA gene polymorphisms reveal different risk in gastric and duodenal ulcer patients.

Lanas A, García-González MA, Santolaria S, Crusius JB, Serrano MT, Benito R, Peña AS.

Genes Immun. 2001 Dec;2(8):415-21.

17.

Role of host interleukin 1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in clinical outcomes in Helicobacter pylori-positive Turkish patients with dyspepsia.

Erzin Y, Koksal V, Altun S, Dobrucali A, Aslan M, Erdamar S, Goksel S, Dirican A, Kocazeybek B.

J Gastroenterol. 2008;43(9):705-10. doi: 10.1007/s00535-008-2220-7. Epub 2008 Sep 20.

PMID:
18807132
18.

Predominant mucosal IL-8 mRNA expression in non-cagA Thais is risk for gastric cancer.

Yamada S, Kato S, Matsuhisa T, Makonkawkeyoon L, Yoshida M, Chakrabandhu T, Lertprasertsuk N, Suttharat P, Chakrabandhu B, Nishiumi S, Chongraksut W, Azuma T.

World J Gastroenterol. 2013 May 21;19(19):2941-9. doi: 10.3748/wjg.v19.i19.2941.

19.

Interleukin-6 genetic polymorphisms are not related to Helicobacter pylori-associated gastroduodenal diseases.

Hwang IR, Hsu PI, Peterson LE, Gutierrez O, Kim JG, Graham DY, Yamaoka Y.

Helicobacter. 2003 Apr;8(2):142-8.

PMID:
12662382
20.

Association of PSCA rs2294008 gene variants with poor prognosis and increased susceptibility to gastric cancer and decreased risk of duodenal ulcer disease.

García-González MA, Bujanda L, Quintero E, Santolaria S, Benito R, Strunk M, Sopeña F, Thomson C, Pérez-Aisa A, Nicolás-Pérez D, Hijona E, Carrera-Lasfuentes P, Piazuelo E, Jiménez P, Espinel J, Campo R, Manzano M, Geijo F, Pellise M, Zaballa M, González-Huix F, Espinós J, Titó L, Barranco L, Pazo-Cid R, Lanas A.

Int J Cancer. 2015 Sep 15;137(6):1362-73. doi: 10.1002/ijc.29500. Epub 2015 Mar 19.

Supplemental Content

Support Center